Chandan Healthcare Ltd
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]
- Market Cap ₹ 595 Cr.
- Current Price ₹ 243
- High / Low ₹ 358 / 179
- Stock P/E 20.5
- Book Value ₹ 56.5
- Dividend Yield 0.00 %
- ROCE 28.8 %
- ROE 27.1 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 29.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 17.8 days to 75.4 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of Nifty SME Emerge
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 120 | 137 | 177 | 230 | |
| 117 | 128 | 150 | 189 | |
| Operating Profit | 2 | 9 | 26 | 41 |
| OPM % | 2% | 7% | 15% | 18% |
| 0 | 0 | 1 | 2 | |
| Interest | 2 | 2 | 3 | 5 |
| Depreciation | 2 | 2 | 3 | 7 |
| Profit before tax | -1 | 5 | 21 | 32 |
| Tax % | 3% | 28% | 24% | 27% |
| -1 | 3 | 16 | 24 | |
| EPS in Rs | -0.56 | 1.68 | 8.14 | 9.07 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 24% |
| TTM: | 26% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 180% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 32% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 30% |
| Last Year: | 27% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 24 | 24 |
| Reserves | 4 | 7 | 21 | 98 | 114 |
| 17 | 21 | 36 | 48 | 67 | |
| 41 | 49 | 41 | 40 | 68 | |
| Total Liabilities | 82 | 98 | 118 | 211 | 273 |
| 29 | 33 | 48 | 76 | 91 | |
| CWIP | 0 | 0 | 0 | 4 | 5 |
| Investments | 6 | 7 | 3 | 1 | 47 |
| 46 | 58 | 66 | 129 | 130 | |
| Total Assets | 82 | 98 | 118 | 211 | 273 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 6 | 4 | 1 | -29 | |
| -11 | -6 | -15 | -36 | |
| 3 | 2 | 16 | 67 | |
| Net Cash Flow | -1 | 0 | 2 | 2 |
| Free Cash Flow | -1 | -1 | -18 | -68 |
| CFO/OP | 275% | 60% | 23% | -50% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 88 | 63 | 59 | 74 |
| Inventory Days | 46 | 71 | 96 | 126 |
| Days Payable | 185 | 251 | 102 | 102 |
| Cash Conversion Cycle | -51 | -117 | 53 | 98 |
| Working Capital Days | -11 | -21 | -1 | 75 |
| ROCE % | 16% | 37% | 29% |
Insights
In beta| Mar 2023 | Mar 2024 | Sep 2025 | |
|---|---|---|---|
| Geographic Presence (States) Number |
|
||
| Number of Diagnostic Centres Number |
|||
| Total Patient Count Lakhs |
|||
| Total Tests Conducted Lakhs |
|||
| Number of Collection Centres Number |
|||
| Number of Pharmacy Stores Number |
|||
| Pathology Tests Offered Number |
|||
| Radiology Tests Offered Number |
|||
| Revenue per patient INR |
|||
Extracted by Screener AI
Documents
Announcements
-
Outcome of Board Meeting
29 May 2026 - Board approved FY26 audited standalone and consolidated results, reappointed internal and cost auditors, and noted IPO fund utilisation.
-
Analysts/Institutional Investor Meet/Con. Call Updates
26 May 2026 - Post-earnings conference call scheduled for 1 June 2026 to discuss Q4 and FY26 results.
-
Disclosure under SEBI Takeover Regulations
26 May 2026 - Promoters filed FY26 declaration confirming no encumbrance on their shares.
-
General Updates
21 May 2026 - Clarifies complaint on 20 May 2026 has no financial impact; DIMSL not under company control.
-
General Updates
20 May 2026 - NSE sought clarification on complaint over IPO RHP disclosures dated February 4, 2025.
Concalls
-
Feb 2026Transcript PPT
-
Dec 2025Transcript PPT
-
Nov 2025TranscriptPPT REC
-
Aug 2025TranscriptAI SummaryPPT
Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points